Johnson & Johnson's commitment to innovative health care products has resulted in consistent financial performance. The Company has 31 consecutive years of adjusted earnings increases and 52 consecutive years of dividend increases.
Johnson & Johnson, through its family of companies, employs approximately 127,500 people worldwide and is engaged in the research and development, manufacture and sale of a broad range of products in the health care field in virtually all countries of the world. Johnson & Johnson's primary interest, both historically and currently, has been in products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
Johnson & Johnson is organized on the principle of decentralized management. The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of resources of the Johnson & Johnson Family of Companies. Johnson & Johnson's operating companies are organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. A Group Operating Committee, composed of managers who represent key operations within the segment, as well as management in specialized functional departments, oversees and coordinates the activities of domestic and international companies related to each of the business segments. However, in line with the principle of decentralized management, senior management groups at U.S. and international operating companies are each responsible for their own strategic plans, as well as the day-to-day operations of those companies, and each international company is, with some exceptions, managed by citizens of the country where it is located.
Shareholder Information Exchange
New York Stock Exchange
Stock Quote (JNJ)
Minimum 20 minutes delayed
JNJ Common Stock